Krystal Biotech, Inc. (KRYS)
246.54
-1.34
(-0.54%)
USD |
NASDAQ |
Dec 31, 16:00
246.71
+0.17
(+0.07%)
After-Hours: 20:00
Krystal Biotech Total Assets (Quarterly): 1.240B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DexCom, Inc. | 7.50B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Vanda Pharmaceuticals, Inc. | 601.14M |
| ADMA Biologics, Inc. | 568.69M |
| Aldeyra Therapeutics, Inc. | 77.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 102.22M |
| Shareholders Equity (Quarterly) | 1.138B |
| Debt to Equity Ratio | 0.0084 |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | -0.01% |